Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioLargo, Inc.
Westminster, California, United Statesbiolargo.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Clyra Medical's FDA-cleared wound care products (e.g., ViaCLYR™ using Clyrasept™) are launching via distribution agreements covering thousands of U.S. healthcare facilities; active commercialization across environmental and health technologies.
- Therapeutic areas
- OtherDermatologyInfectious Diseases
- Modalities
- Antimicrobial solutionAntimicrobial productsWater treatment technologyBattery energy storage
- Industry
- Therapeutic Medical Devices
02
Partnerships
Sales/distribution agreements for Clyra products (U.S./international covering 6,100 hospitals, etc.)Advanced Solution (wound care distribution)prospective JVs for Cellinity batteries
Beyond the preview
Go deeper on BioLargo, Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on BioLargo, Inc..